Corvus Pharmaceuticals (FRA:C17) Cyclically Adjusted Book per Share: €2.60 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C17 Corvus Pharmaceuticals Inc FRA:C17
32 GF Score
Price €11.47
! 1 Warning Sign
View Full Analysis

What is Corvus Pharmaceuticals Cyclically Adjusted Book per Share?

Corvus Pharmaceuticals FRA:C17 -1.92% 32 Cyclically Adjusted Book per Share is €2.60 as of Jun. 2026. GuruFocus rates FRA:C17 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Corvus Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was €2.117. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.60 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Corvus Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-09), Corvus Pharmaceuticals's current stock price is €11.465. Corvus Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €2.60. Corvus Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 4.41.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Corvus Pharmaceuticals was 4.42. The lowest was 0.00. And the median was 0.00.


Corvus Pharmaceuticals  (FRA:C17) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Corvus Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.465/2.60
=4.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Corvus Pharmaceuticals was 4.42. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Corvus Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Corvus Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Corvus Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corvus Pharmaceuticals Cyclically Adjusted Book per Share Chart

Corvus Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 3.03 2.76

Corvus Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 2.77 2.76 2.57 2.60

FRA:C17 vs MGTX, WVE, FBRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Corvus Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corvus Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corvus Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Corvus Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


FRA:C17
32GF Score
Corvus Pharmaceuticals Inc FRA:C17
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corvus Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corvus Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.117/333.9520*333.9520
=2.117

Current CPI (Jun. 2026) = 333.9520.

Corvus Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 6.089 241.428 8.423
201612 6.017 241.432 8.323
201703 5.280 243.801 7.232
201706 4.455 244.955 6.074
201709 3.755 246.819 5.081
201712 3.407 246.524 4.615
201803 3.814 249.554 5.104
201806 3.735 251.989 4.950
201809 3.478 252.439 4.601
201812 3.307 251.233 4.396
201903 3.039 254.202 3.992
201906 2.704 256.143 3.525
201909 2.483 256.759 3.229
201912 2.290 256.974 2.976
202003 1.944 258.115 2.515
202006 1.610 257.797 2.086
202009 1.281 260.280 1.644
202012 2.090 260.474 2.680
202103 2.070 264.877 2.610
202106 1.886 271.696 2.318
202109 1.920 274.310 2.337
202112 1.847 278.802 2.212
202203 1.750 287.504 2.033
202206 1.633 296.311 1.840
202209 1.403 296.808 1.579
202212 1.138 296.797 1.280
202303 0.980 301.836 1.084
202306 0.934 305.109 1.022
202309 0.846 307.789 0.918
202312 0.723 306.746 0.787
202403 0.626 312.332 0.669
202406 0.761 314.175 0.809
202409 0.179 315.301 0.190
202412 0.458 315.605 0.485
202503 0.669 319.799 0.699
202506 0.933 322.561 0.966
202509 0.819 324.800 0.842
202512 0.700 324.054 0.721
202603 2.476 330.213 2.504
202606 2.117 333.952 2.117

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €2.60 mean?
Corvus Pharmaceuticals (FRA:C17) has a Cyclically Adjusted Book per Share of €2.60 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Corvus Pharmaceuticals and its competitors.
Is Corvus Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Corvus Pharmaceuticals' current Cyclically Adjusted Book per Share is €2.60. Overall, Corvus Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Corvus Pharmaceuticals' Cyclically Adjusted Book per Share compare to MGTX and WVE?
Corvus Pharmaceuticals' Cyclically Adjusted Book per Share of €2.60 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Corvus Pharmaceuticals and its competitors. Corvus Pharmaceuticals's current Cyclically Adjusted Book per Share is €2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corvus Pharmaceuticals stock overvalued right now?
Corvus Pharmaceuticals (FRA:C17) has a current Cyclically Adjusted Book per Share of €2.60. The current Cyclically Adjusted Book per Share is €2.60. Corvus Pharmaceuticals' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Corvus Pharmaceuticals (FRA:C17), the current Cyclically Adjusted Book per Share is €2.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corvus Pharmaceuticals Business Description

Other Exchanges CRVS:USAC17:Germany
Address 901 Gateway Boulevard, Third Floor, South San Francisco, CA, USA, 94080
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
32GF Score

Get the complete analysis for FRA:C17

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.47
Price